Cargando…
Corrections to “Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab”
Autores principales: | Lenihan, D., Suter, T., Brammer, M., Neate, C., Ross, G., Baselga, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340184/ https://www.ncbi.nlm.nih.gov/pubmed/30624607 http://dx.doi.org/10.1093/annonc/mdy533 |
Ejemplares similares
-
Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies
Publicado: (2021) -
Corrections to “Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer”
por: Baselga, J., et al.
Publicado: (2019) -
Corrigendum: Radiocarbon constraints on the extent and evolution of the South Pacific glacial carbon pool
por: Ronge, T. A., et al.
Publicado: (2016) -
Corrigendum: Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety?
por: Le Guennec, Jean-Yves, et al.
Publicado: (2017) -
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer
por: Dang, Chau, et al.
Publicado: (2022)